Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilberto Lopes

Showing results (101-110 of 177) with videos related to

Pageof 18
Sort By:
Translational Lung Cancer Research|January 9, 2026
A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patientsNicolas Girard, Daniel Tan, Diego Cortinovis, et al.
Cancers|June 27, 2024
Does a "Western Lifestyle" Confer a Higher Burden of Colorectal Cancer? A Comparison of EU15+ Countries versus Global Trends between 1990 and 2019Bradley Walker, Chinmay T Jani, Weitao Liu, et al.
American Journal of Clinical Oncology|May 10, 2011
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancerJaime R Merchan, Annaporna Ferrell, Jessica Macintyre, et al.
Infectious Agents and Cancer|May 30, 2019
Cancer care workforce in Africa: perspectives from a global surveyVerna Vanderpuye, Nazik Hammad, Yehoda Martei, et al.
Drugs in Context|November 13, 2018
A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitorsMariane Teodoro Fernandes, Jacob J Adashek, Carmelia Maria Noia Barreto, et al.
Cancers|October 14, 2022
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant WaveSamuel A Kareff, Aliya Khan, Priscila Barreto-Coelho, et al.
Seminars in Oncology|January 28, 2019
Medical oncology job satisfaction: Results of a global surveyMichael J Raphael, Adam Fundytus, Wilma M Hopman, et al.
Clinical Breast Cancer|July 16, 2008
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancerOrlando Silva, Gilberto Lopes, Daniel Morgenzstern, et al.
Cancers|June 12, 2026
Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS MetastasesSantiago Sucre, Chinmay Jani, Dan Morgenstern-Kaplan, et al.
Immunotherapy|July 3, 2026
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysisNicolas Peruzzo, Gabriel Lenz, Rafael Alvim Pereira, et al.
Pageof 18

Showing results (101-110 of 177) with videos related to

Sort By:
Pageof 18
Translational Lung Cancer Research|January 9, 2026
A systematic literature review and meta-analysis on the efficacy and safety of PD-(L)1 inhibitors for the first- and second-line treatment of locally advanced or metastatic non-small cell lung cancer in Asian and non-Asian patientsNicolas Girard, Daniel Tan, Diego Cortinovis, et al.
Cancers|June 27, 2024
Does a "Western Lifestyle" Confer a Higher Burden of Colorectal Cancer? A Comparison of EU15+ Countries versus Global Trends between 1990 and 2019Bradley Walker, Chinmay T Jani, Weitao Liu, et al.
American Journal of Clinical Oncology|May 10, 2011
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancerJaime R Merchan, Annaporna Ferrell, Jessica Macintyre, et al.
Infectious Agents and Cancer|May 30, 2019
Cancer care workforce in Africa: perspectives from a global surveyVerna Vanderpuye, Nazik Hammad, Yehoda Martei, et al.
Drugs in Context|November 13, 2018
A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitorsMariane Teodoro Fernandes, Jacob J Adashek, Carmelia Maria Noia Barreto, et al.
Cancers|October 14, 2022
Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 ("Omicron") SARS-CoV-2 Variant WaveSamuel A Kareff, Aliya Khan, Priscila Barreto-Coelho, et al.
Seminars in Oncology|January 28, 2019
Medical oncology job satisfaction: Results of a global surveyMichael J Raphael, Adam Fundytus, Wilma M Hopman, et al.
Clinical Breast Cancer|July 16, 2008
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-negative metastatic breast cancerOrlando Silva, Gilberto Lopes, Daniel Morgenzstern, et al.
Cancers|June 12, 2026
Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS MetastasesSantiago Sucre, Chinmay Jani, Dan Morgenstern-Kaplan, et al.
Immunotherapy|July 3, 2026
Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysisNicolas Peruzzo, Gabriel Lenz, Rafael Alvim Pereira, et al.
Pageof 18